Novel drug developmental strategies for treatment‐resistant depression

Major depressive disorder is a leading cause of disability worldwide. Because conventional therapies are ineffective in many patients, novel strategies are needed to overcome treatment‐resistant depression (TRD). Limiting factors of successful drug development in the last decades were the lack of (1...

Descripción completa

Detalles Bibliográficos
Autores principales: Borbély, Éva, Simon, Mária, Fuchs, Eberhard, Wiborg, Ove, Czéh, Boldizsár, Helyes, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303797/
https://www.ncbi.nlm.nih.gov/pubmed/34822719
http://dx.doi.org/10.1111/bph.15753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303797/
https://www.ncbi.nlm.nih.gov/pubmed/34822719
http://dx.doi.org/10.1111/bph.15753

Ejemplares similares